DUBLIN--(BUSINESS WIRE)--The "Neurontin - API Insight,2018" drug pipelines has been added to ResearchAndMarkets.com's offering.
This report provides product and API manufacturers' details across the globe along with the location. The report gives the clear idea on the country wise DMF filed by worldwide companies related to Neurontin . The report also highlights the patent details of Neurontin.
Scope
- A comprehensive product overview including product description, regulatory milestones, safety, pharmacological properties, clinical trials, and product development activities have been elaborated in this report
- Patent information around Neurontin in United States (US) and Europe (EU) has been highlighted
- API manufacturers for Neurontin in United States, Europe, China and India
- The report contains historical and forecasted sales for Neurontin till 2020
- Enlists the market competition and emerging therapies in the space where Neurontin operates
Reasons to Purchase
- Evaluate the marketing status of Neurontin to exploit opportunities for generic Neurontin development opportunities
- Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details with respect to Neurontin
- API intelligence over Neurontin and gaining primary intelligence over Active Ingredient manufacturers by country
- Make more informed business decisions from insightful and in-depth analysis of the Neurontin 's performance
Key Topics Covered
1. Neurontin Overview
2. Neurontin Global Sales Assessment
- Neurontin Historical Global Sales
- Neurontin Forecasted Global Sales
3. Product Description
- Mechanism of Action
- Pharmacodynamic Properties
- Pharmacokinetic Properties
4. Product Details by country
5. Patent Information
6. Global API Manufacturers Assessment
- Active Pharmaceutical Ingredient (API) Manufacturers by Country
- Active Pharmaceutical Ingredient (API) Manufacturers by Region
List of Tables
Table 1: Neurontin Historical Global Sales till 2017 (in million USD)
Table 2: Neurontin Forecasted Global Sales from 2018-2020 (in million USD)
Table 3: Neurontin General Description
Table 4: Product Details by country
Table 5: Patent Information
Table 6: API Manufacturers by country
Table 7: API Manufacturers by Region
List of Figures
Figure 1: Neurontin Historical Global Sales till 2017 (in million USD)
Figure 2: Neurontin Forecasted Global Sales from 2018-2020 (in million USD)
Figure 3: Neurontin Patent Details
Figure 4: API Manufacturers by Country
Figure 5: API Manufacturers by Region
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/4nfkcj/neurontin_api?w=4
